Proximal femoral replacement for non-oncologic reconstruction: functional outcomes and survivorship in 30 patients
HIP International · 2026-11 · 36 (6) · 891-898
DOI: 10.1177/11207000261459288 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIP International, online erschienen am 05.08.2026. Verfasst von Edgar Manuel Bodu Lamberti und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of La Sabana, Chía, Colombia. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
Proximal femoral replacement (PFR) is a useful salvage option for reconstruction after massive proximal femoral bone loss. However, functional outcomes in non-oncologic cases remain underreported. The purpose of this study was to evaluate postoperative function, complications, and implant survival after PFR performed for non-oncologic indications.
Methods
We retrospectively reviewed 63 consecutive non-oncologic PFRs performed between 2018 and 2023. After applying exclusion criteria and accounting for duplicates and patients lost to follow-up, 30 participants were available for final evaluation. The primary outcome was the postoperative modified Harris Hip Score (mHHS). Secondary outcomes included postoperative complications, infection-free survival, and revision-free arthroplasty survival. Univariate linear regression analyses were performed to identify factors associated with postoperative mHHS.
Results
The study cohort included 30 patients (63.3% female) with a mean age of 64.4 ± 13.6 years and mean follow-up of 31.4 months. The mean postoperative mHHS was 54.0 ± 22.4. Male patients demonstrated higher unadjusted mHHS than females (69.2 ± 18.5 vs. 45.2 ± 19.8; p = 0.003). The Kaplan-Meier estimated infection-free survival was 96.4% (95% CI, 89.8–100%) at 12 months, 91.4% (95% CI, 80.4–100%) at 24 months, and 73.1% (95% CI, 46.3–100%) at 60 months. Revision arthroplasty survival was 85.1% (95% CI, 68%, 100%) at 12 and 24 months, and 49.7% (95% CI, 25.6–96.3%) at 60 months. Overall complications occurred in 15 patients (50%), with periprosthetic joint infection being the most frequent ( n = 4, 13.3%).
Conclusions
PFR for non-oncologic indications provides modest limb salvage and functional outcomes, although complications remain common. Functional recovery appears multifactorial and not solely dependent on implant design or fixation method. These findings may support the use of PFR as a salvage option in carefully selected non-oncologic cases, while emphasizing the need for larger prospective studies to improve patient selection and outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of La Sabana, Chía, Colombia.
- Clínica Palermo, Bogotá, Colombia.
ORCID-Profile: Edgar Manuel Bodu Lamberti
Zitieren
APA
Bodu Lamberti, E. M., Monclou, G., & Karduss Preciado, C. (2026). Proximal femoral replacement for non-oncologic reconstruction: functional outcomes and survivorship in 30 patients. HIP International, 36(6), 891-898. https://doi.org/10.1177/11207000261459288
Vancouver
Bodu Lamberti EM, Monclou G, Karduss Preciado C. Proximal femoral replacement for non-oncologic reconstruction: functional outcomes and survivorship in 30 patients. HIP International. 2026;36(6):891-898. doi:10.1177/11207000261459288
BibTeX
@article{BoduLamberti2026,
author = {Bodu Lamberti, Edgar Manuel and Monclou, Gary and Karduss Preciado, Camila},
title = {Proximal femoral replacement for non-oncologic reconstruction: functional outcomes and survivorship in 30 patients},
journal = {HIP International},
year = {2026},
volume = {36},
number = {6},
pages = {891--898},
doi = {10.1177/11207000261459288}
}
EUVIMED